AnaptysBio, Inc.
USD51.26
-1.88 (-3.54%)
CEO
Daniel R. Faga
IPO Date
2017-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$52.34
Prev. Close
$53.14
Day Low
$50.46
Day High
$52.34
52W Low
$11.40
52W High
$72.36
Market Cap
$2.21B
Volume
0.72M
| $0.00 |
| 13 May 2026 | Murphy Christopher M. | Chief Financial Officer | A-Award | Acquired | 25,765 | $0.00 |
| 13 May 2026 | Murphy Christopher M. | — | Disposed | 0 | $0.00 |
| 29 Apr 2026 | GRAY SUSANNAH | director | A-Award | Acquired | 11,250 | $0.00 |
| 23 Apr 2026 | Faga Daniel | director, officer: President, CEO | D-Return | Disposed | 11,000 | $31.12 |
| 22 Apr 2026 | Orwin John A | director | D-Return | Disposed | 3,311 | $19.50 |
| 22 Apr 2026 | Orwin John A | director | A-Award | Acquired | 3,311 | $14.29 |
| 22 Apr 2026 | Orwin John A | director | D-Return | Disposed | 10,600 | $19.50 |
| 22 Apr 2026 | Orwin John A | director | A-Award | Acquired | 10,600 | $14.29 |